Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference

We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups, SMEs and larger companies. This includes clients who focus on their own product development, but also strong partnerships with the services industry like CROs, formulation partners, clinical trials experts and regulatory experts.

View some example cases

 

Khondrion – in search of treatment for mitochondrial diseases

Khondrion – in search of treatment for mitochondrial diseases

Interview with Jan Smeitink, CEO of Khondrion Eight years ago, Jan Smeitink looked at himself in the mirror and decided he is going to change the world. Today, Jan is the Chief Executive Officer of Khondrion and is starting Phase 2b clinical trials for his revolutionary drug, KH176 – which might well become the first…

Nutrileads

Nutrileads

Meet Nutrileads – one of today’s leading innovative companies to have recently received the prestigious SME Phase 2 Award. Although winning such a grant can feel “like winning the lottery”, the success of Nutrileads is much more than luck. To learn more about their inspiring story we interviewed Erik Dam, the Chief Business Office of…

TRiCares

TRiCares

TRiCares, a French-German medical device company, has been awarded a prestigious Horizon 2020 SME Instrument Phase 2 grant to bring the unique heart valve replacement system to clinical readiness.

REACTION!

REACTION!

The REACTION! Project comprises a direct-aid response to the EBOLA crisis in 2015. The project was initiated by an international project team to provide rapid aid and health-care to the Ebola-infected population in Guinea, and by directly collecting rapid evidence of the efficacy of Favipiravir in reducing the mortality and Ebola viral load in the…

SkylineDx; novel gene-expression profiling technology

SkylineDx; novel gene-expression profiling technology

SkylineDx has been awarded a multi-million euro Horizon2020 grant from the European Commission to develop a new, and novel gene-expression profiling technology, which is intended to predict the most effective treatment strategy for patients with multiple myeloma (MM).

INCISION Academy next step towards universal surgical language

INCISION Academy next step towards universal surgical language

The SurgASSIST project aims to improve surgical care by changing the way surgeons are educated. The SurgASSIST project provides an online educational program, the INCISION Academy, that uses 3D visualizations (stereoscopic videos and animations) to teach surgical procedures step-by-step, based on state-of-the-art scientific research and best-practice surgical care.

Novel drug delivery method for DR patients

Novel drug delivery method for DR patients

PREVIN combines a novel drug delivery method to treat patients with Diabetic Retinopathy (DR) (i.e. blindness in Diabetes patients) with established drugs.

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive3D has received a prestigious €1.3 EU million grant from the Horizon 2020 SME Instrument Phase 2 funding to develop in.nav. In.nav is the first system for intra-operative navigation based on video.

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or